COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.
Luciano Gattinoni,Silvia Coppola,Massimo Cressoni,Mattia Busana,Sandra Rossi,Davide Chiumello +5 more
Reads0
Chats0
TLDR
It is found that hypercapnia was common in patients with COVID-19–associated ARDS while using low VT ventilation, and low VT may not be the best approach for all patients with ARDS, particularly those with a less severe decrease in respiratory system compliance and inadequacy of ventilation.Abstract:
ventilation strategy was applied to the first four patients to increase pulmonary efficiency to eliminate CO2, and this was used in the next four patients. Gas exchange consists of oxygenation and ventilation. Oxygenation is quantified by the PaO2/FIO2 ratio, and this method has gained wide acceptance, particularly since publication of the Berlin definition of ARDS (7). However, the Berlin definition does not include additional pathophysiological information about ARDS, such as alveolar ventilation, as measured by pulmonary dead space, which is an important predictor of outcome (8). Increased pulmonary dead space reflects the inefficiency of the lungs to eliminate CO2, which may lead to hypercapnia. In our patients with ARDS with COVID-19, hypercapnia was common at ICU admission with low VT ventilation. Assuming the anatomic portion of dead space is constant, increasing VT with constant respiratory rate would effectively increase alveolar ventilation. Any such increase in VT would decrease PaCO2, which would be captured by VR (6). VR, a novel method to monitor ventilatory adequacy at the bedside (4–6), was very high in our patients, reflecting increased pulmonary dead space and inadequacy of ventilation. With an acceptable plateau pressure and driving pressure, titration of VT was performed. PaCO2 and VR were significantly decreased when an intermediate VT (7–8 ml/kg PBW) was applied. We suggest that intermediate VT (7–8 ml/kg PBW) is recommended for such patients. Therefore, low VT may not be the best approach for all patients with ARDS, particularly those with a less severe decrease in respiratory system compliance and inadequacy of ventilation. In summary, we found that hypercapnia was common in patients with COVID-19–associated ARDS while using low VT ventilation. VR was increased in these patients, which reflected increased pulmonary dead space and inadequacy of ventilation. An intermediate VT was used to correct hypercapnia efficiently, while not excessively increasing driving pressure. Clinicians must have a high index of suspicion for increased pulmonary dead space when patients with COVID19–related ARDS present with hypercapnia. nread more
Citations
More filters
Journal ArticleDOI
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.
Prashant Nasa,Elie Azoulay,Ashish Khanna,Ravi Jain,Sachin Gupta,Yash Javeri,Deven Juneja,Pradeep Rangappa,Krishnaswamy Sundararajan,Waleed Alhazzani,Massimo Antonelli,Yaseen M. Arabi,Jan Bakker,Jan Bakker,Jan Bakker,Laurent Brochard,Adam M. Deane,Bin Du,Sharon Einav,Andrés Esteban,Ognjen Gajic,Samuel M. Galvagno,Claude Guérin,Samir Jaber,Gopi C. Khilnani,Younsuck Koh,Jean-Baptiste Lascarrou,Flávia Ribeiro Machado,Manu L N G Malbrain,Jordi Mancebo,Michael T. McCurdy,Brendan McGrath,Sangeeta Mehta,Armand Mekontso-Dessap,Mervyn Mer,Michael Nurok,Pauline K. Park,Paolo Pelosi,John Victor Peter,Jason Phua,David Pilcher,Lise Piquilloud,Peter Schellongowski,Marcus J. Schultz,Marcus J. Schultz,Marcus J. Schultz,Manu Shankar-Hari,Manu Shankar-Hari,Suveer Singh,Massimiliano Sorbello,Ravindranath Tiruvoipati,Andrew A. Udy,Tobias Welte,Sheila Nainan Myatra +53 more
TL;DR: Using a Delphi process, an international panel of experts developed clinical practice statements on the respiratory management of COVID-19-related acute respiratory failure (C-ARF) in areas where evidence is absent or limited as discussed by the authors.
Journal ArticleDOI
SARS-CoV-2 and COVID-19: From the Bench to the Bedside.
TL;DR: Changes in the evolution of the disease are reviewed and drugs currently used to treat COVID-19 (antiviral drugs, antimalarial drugs, immunomodulators, anticoagulants, and antibodies) should be evaluated in relation to the pathophysiology of disease progression.
Journal ArticleDOI
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19: A Living Systematic Review of Multiple Streams of Evidence.
Holger J. Schünemann,Joanne Khabsa,Karla Solo,Assem M. Khamis,Romina Brignardello-Petersen,Amena El-Harakeh,Andrea Darzi,Anisa Hajizadeh,Antonio Bognanni,Anna Bak,Ariel Izcovich,Carlos A. Cuello-Garcia,Chen Chen,Ewa Borowiack,Fatimah Chamseddine,Finn Schünemann,Gian Paolo Morgano,Giovanna E. U. Muti-Schünemann,Guang Chen,Hong Zhao,Ignacio Neumann,Jan Brozek,Joel Schmidt,Layal Hneiny,Leila Harrison,Marge Reinap,Mats Junek,Nancy Santesso,Rayane El-Khoury,Rebecca Thomas,Robby Nieuwlaat,Rosa Stalteri,Sally Yaacoub,Tamara Lotfi,Tejan Baldeh,Thomas Piggott,Yuan Zhang,Zahra Saad,Bram Rochwerg,Dan Perri,Eddy Fan,Florian Stehling,Imad Bou Akl,Mark Loeb,Paul Garner,Stephen Aston,Waleed Alhazzani,Wojciech Szczeklik,Derek K. Chu,Elie A. Akl +49 more
TL;DR: Indirect and low-certainty evidence suggests that use of NIV, similar to IMV, probably reduces mortality but may increase the risk for transmission of COVID-19 to health care workers.
Journal ArticleDOI
Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal.
Dejan Radovanovic,Maurizio Rizzi,Stefano Pini,Marina Saad,Davide Chiumello,Pierachille Santus +5 more
TL;DR: The rationale and some important considerations about timing, criteria, and monitoring requirements for patients with COVID-19 respiratory failure requiring a CPAP treatment are discussed.
Journal ArticleDOI
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.
Kiandokht Keyhanian,Raffaella Pizzolato Umeton,Babak Mohit,Vahid Davoudi,Fatemeh Hajighasemi,Mehdi Ghasemi +5 more
TL;DR: This Review discusses the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroIMmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.
References
More filters
Journal ArticleDOI
Acute respiratory distress syndrome: the Berlin Definition.
Ards Definition Task Force,V. Marco Ranieri,Gordon D. Rubenfeld,B. Taylor Thompson,Niall D. Ferguson,Ellen Caldwell,Eddy Fan,Luigi Camporota,Luigi Camporota,Arthur S. Slutsky +9 more
TL;DR: The updated and revised Berlin Definition for ARDS addresses a number of the limitations of the AECC definition and may serve as a model to create more accurate, evidence-based, critical illness syndrome definitions and to better inform clinical care, research, and health services planning.
Journal ArticleDOI
Lung Recruitment in Patients with the Acute Respiratory Distress Syndrome
Luciano Gattinoni,Pietro Caironi,Massimo Cressoni,Davide Chiumello,V. Marco Ranieri,Michael Quintel,Sebastiano G. Russo,Nicolò Patroniti,Rodrigo Cornejo,Guillermo Bugedo +9 more
TL;DR: In ARDS, the percentage of potentially recruitable lung is extremely variable and is strongly associated with the response to PEEP, which may decrease ventilator-induced lung injury by keeping lung regions open that otherwise would be collapsed.
Journal ArticleDOI
Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure
TL;DR: It is argued that application of a lung-protective ventilation, today best applied with sedation and endotracheal intubation, might be considered a prophylactic therapy, rather than just a supportive therapy, to minimize the progression of lung injury from a form of patient self-inflicted lung injury.
Journal ArticleDOI
Prone Position in Acute Respiratory Distress Syndrome. Rationale, Indications, and Limits
TL;DR: The bulk of data indicates that in severe acute respiratory distress syndrome, carefully performed prone positioning offers an absolute survival advantage of 10-17%, making this intervention highly recommended in this specific population subset.
Journal ArticleDOI
Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
Chun Pan,Lu Chen,Cong Lu,Cong Lu,Wei Zhang,Jia An Xia,Michael C. Sklar,Michael C. Sklar,Bin Du,Laurent Brochard,Laurent Brochard,Haibo Qiu +11 more
TL;DR: A new mechanics-based index is described to directly quantify the potential for lung recruitment, called the recruitment-to-inflation ratio (R/I ratio), which estimates how much of an increase in endexpiratory lung volume induced by PEEP is distributed between the recruited lung (recruitment) and the inflation and/or hyperinflation of the “baby lung” when a higher PEP is applied.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more